Palvella Therapeutics Ownership | Who Owns Palvella Therapeutics?

Palvella Therapeutics Ownership Summary

Palvella Therapeutics is owned by 21.08% institutional investors, 21.36% insiders, and 57.56% retail investors. Bvf inc/il is the largest institutional shareholder, holding 10.51% of PVLA shares.

PVLA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Palvella Therapeutics	21.08%	21.36%	57.56%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	1.16M	10.51%	$72.80M
Suvretta capital management	822.40K	7.44%	$51.56M
Frazier life sciences management	722.40K	6.54%	$45.29M
First light asset management	541.54K	4.90%	$33.95M
Vanguard group	494.66K	4.48%	$31.01M
Blackrock funding, inc. /de	487.62K	4.41%	$30.57M
Perceptive advisors	395.09K	3.57%	$24.77M
Woodline partners lp	345.75K	3.13%	$21.68M
Federated hermes	339.05K	3.07%	$21.25M
Point72 asset management	317.31K	2.87%	$19.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Clio asset management	91.64K	4.26%	$5.74M
First light asset management	541.54K	3.20%	$33.95M
Bvf inc/il	1.16M	2.95%	$72.80M
Sectoral asset management	49.12K	1.90%	$3.08M
Blue owl capital lp	95.26K	1.85%	$5.97M
Samsara biocapital	209.63K	1.72%	$13.14M
Frazier life sciences management	722.40K	1.36%	$45.29M
Suvretta capital management	822.40K	1.32%	$51.56M
Perceptive advisors	395.09K	0.72%	$24.77M
Bioimpact capital	67.42K	0.69%	$4.23M

Top Buyers

Holder	Shares	% Assets	Change
First light asset management	541.54K	3.20%	541.54K
Bvf inc/il	1.16M	2.95%	464.69K
Perceptive advisors	395.09K	0.72%	395.09K
Federated hermes	339.05K	0.04%	339.05K
Vanguard group	494.66K	0.00%	330.85K

Top Sellers

Holder	Shares	% Assets	Change
Adams street partners	-	-	-298.99K
Opaleye management	-	-	-172.36K
Samsara biocapital	209.63K	1.72%	-130.11K
Woodline partners lp	345.75K	0.10%	-99.87K
Marshall wace, llp	-	-	-49.08K

New Positions

Holder	Shares	% Assets	Change	Value
First light asset management	541.54K	3.20%	541.54K	$33.95M
Perceptive advisors	395.09K	0.72%	395.09K	$24.77M
Federated hermes	339.05K	0.04%	339.05K	$21.25M
Point72 asset management	317.31K	0.03%	317.31K	$19.89M
Jennison associates	106.91K	0.00%	106.91K	$6.70M

Sold Out

Holder	Change
Sbi securities	-12.00
Balyasny asset management	-8.18K
Xtx topco	-17.70K
Strid group	-18.17K
Dafna capital management	-43.35K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	52	-16.13%	2,330,158	-59.04%	21	0.80%	33	-19.51%	11	22.22%
Jun 30, 2025	65	62.50%	5,909,711	15.35%	53	2.47%	44	91.30%	9	125.00%
Mar 31, 2025	40	21.21%	5,124,167	27.05%	230	0.70%	24	71.43%	4	-33.33%
Dec 31, 2024	33	37.50%	4,033,115	565.98%	181	24.48%	14	40.00%	6	-
Sep 30, 2024	24	26.32%	605,591	67.17%	27	10.27%	10	-47.37%	6	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 19, 2025	Goin Kathleen	Chief Operating Officer	Sell	$128.58K
Nov 19, 2025	Goin Kathleen	Chief Operating Officer	Sell	$242.39K
Apr 09, 2025	JENKINS GEORGE M	-	Buy	$50.33K
Apr 09, 2025	JENKINS GEORGE M	-	Buy	$50.47K
Dec 18, 2024	JENKINS GEORGE M	-	Buy	$51.72K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	2
2025 Q2	2	-
2025 Q1	-	-
2024 Q4	1	-

PVLA Ownership FAQ

Who Owns Palvella Therapeutics?

Palvella Therapeutics shareholders are primarily institutional investors at 21.08%, followed by 21.36% insiders and 57.56% retail investors. The average institutional ownership in Palvella Therapeutics's industry, Biotech Stocks , is 45.24%, which Palvella Therapeutics falls below.

Who owns the most shares of Palvella Therapeutics?

Palvella Therapeutics’s largest shareholders are Bvf inc/il (1.16M shares, 10.51%), Suvretta capital management (822.4K shares, 7.44%), and Frazier life sciences management (722.4K shares, 6.54%). Together, they hold 24.48% of Palvella Therapeutics’s total shares outstanding.

Does Blackrock own Palvella Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Palvella Therapeutics.

Who is Palvella Therapeutics’s biggest shareholder by percentage of total assets invested?

Clio asset management is Palvella Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.26% of its assets in 91.64K Palvella Therapeutics shares, valued at 5.74M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools